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Background: A significant number of studies on pig farms and wild boars worldwide, demonstrate the endemic
presence of Chlamydia suis in pigs. However, the zoonotic potential of this pathogen, phylogenetically closely
related to Chlamydia trachomatis, is still uninvestigated. Therefore, this study aims to examine the zoonotic
transmission in a Belgian pig abattoir.
Methods: Presence of Chlamydia suis in pigs, contact surfaces, air and employees was assessed using a Chlamydia
suis specific real-time PCR and culture. Furthermore, Chlamydia suis isolates were tested for the presence of the tet(C)
gene.
Results: Chlamydia suis bacteria could be demonstrated in samples from pigs, the air and contact surfaces. Moreover,
eye swabs of two employees were positive for Chlamydia suis by both PCR and culture. The tet(C) gene was absent in
both human Chlamydia suis isolates and no clinical signs were reported.
Conclusions: These findings suggest the need for further epidemiological and clinical research to elucidate the
significance of human ocular Chlamydia suis infections.
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The negative influence of Chlamydiaceae infections on
the economic yield of the pig industry is underestimated
[1]. Four chlamydial species are regularly observed in
the pig population: Chlamydia (C.) pecorum, C. abortus,
C. psittaci and C. suis [1]. Chlamydia suis is the most
prevalent and its primary pathogenicity is proven by sev-
eral experimental infections in gnotobiotic pigs [2-8]. In
field, this pathogen is mainly associated with respiratory
disease, diarrhea, conjunctivitis, reproductive failure and
subclinical infections [1,8]. Chlamydiae are generally
highly sensitive to the relatively inexpensive tetracycline
antibiotics. However, the first tetracyline resistant (TcR)
C. suis strains appeared in the U.S. in 1998 [9]. Ever* Correspondence: Kristien.DePuysseleyr@ugent.be
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article, unless otherwise stated.since, infections with C. suis strains have been reported on
Italian [10,11], Estonian [12], Belgian, Cypriot, German,
Israeli [13], Swiss [14] and Dutch [15] pig farms. The ma-
jority of these infections were due to TcR C. suis strains.
Moreover all of these farms suffered from severe repro-
ductive failure leading to marked economic loss.
Exposure to TcR C. suis strains poses an additional risk
for pig handlers. In fact, Suchland et al. [16] demon-
strated horizontal transfer of the tetracycline resistance
gene tet(C) among chlamydial species.
The use of tetracycline antibiotics as treatment for
chlamydial infections in pigs, leads to selection for re-
sistant strains [14]. Consequently, the emergence of TcR
strains requires the use of other, more expensive antibi-
otics and, may become economically devastating to pig
production. Besides the economical consequences, TcR
C. suis strains are also a potential threat to public
health. Contact between TcR C. suis and tetracycline
sensitive C. trachomatis bacteria might lead to creationentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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both strains. Nevertheless, the co-infection of a person
with C. suis and C. trachomatis is only possible if C.
suis is a zoonotic bacteria. Albeit the zoonotic potential
of C. suis is still unexamined, the zoonotic transfer of
C. suis is a plausible hypothesis since C. suis is phylo-
genetically highly related to C. trachomatis, a natural
pathogen of humans [17]. Therefore, the present study
examines the prevalence of C. suis in butcher hogs
(±100 kg) being slaughtered in a Belgian abattoir, and
simultaneously investigates zoonotic transmission. For
this purpose, slaughterhouse employees, air and pos-
sible direct contact surfaces were sampled. Pigs, air and
contact surfaces were diagnosed for TcR C. suis, while
humans were examined for TcR C. suis and C. tracho-
matis. As far as known, the present study is the first
evaluation of the zoonotic potential of C. suis in a pig
slaughterhouse.
Methods
Sampling of pigs and humans
Rayon-tipped aluminium-shafted swabs (Copan; Fiers,
Kuurne, Belgium) were used to sample pigs and humans.
For monitoring C. suis in pigs, rectal swabs (n=100; 10
pigs of 10 Belgian farrowing to slaughter farms) were
taken upon arrival in the slaughterhouse. No information
on clinical signs or medication during the fattening period
was available. Sampling was performed on one day. A
swab for PCR was placed in DNA/RNA stabilization
buffer (Roche) and a swab for culture was immersed in
chlamydia transport medium (2-SP). At the same day,
employees voluntarily provided (informed consent) an
ocular and pharyngeal swab, and they were asked to
bring a fresh stool swab and a first void morning urine
sample the next day. All samples were kept at 4°C and
they were stored at −80°C upon arrival in the labora-
tory. Volunteers filled out a medical questionnaire, in
the presence of a medical doctor, to assess information
on professional (work environment of the employee)
and nonprofessional activities, general health status,
smoking habits, use of medication, allergies and clinical
signs.
This study was approved by the medical ethical commit-
tee of Ghent University (approval EC UZG 2011/459).
Participants provided their written informed consent and
the consent procedure was approved by the medical eth-
ical committee.
Sampling of air and contact surfaces
Bioaerosol monitoring for C. suis was performed using
the MAS-100 Eco sampler (Merck, Darmstadt, Germany)
as previously described [18] at different locations in the
abattoir: the pig reception area (lairage and stunning),
slaughtering and bleeding area, pre-washing bath location,dehairing area, cutting/deboning area, carcass splitting
area, organ evisceration area, individual weighing area,
chilling/hanging room, pig intestine washing room, em-
ployee dining room, and the administrative office. In
addition, also contact surfaces were sampled (water
taps, door handles, tables, knives, start and stop button
of machines) at all these locations by use of rayon-
tipped aluminium-shafted swabs (Copan; Fiers, Kuurne,
Belgium). Swabs were examined by PCR and culture. In
addition, we also sampled water taps and door handles
at the sanitary facilities at the individual weighing area,
the pig intestine washing room and the cloakrooms.
DNA extraction
DNA extraction on urine samples was performed by
the High Pure PCR Template Preparation (HPPTP) Kit
(Roche Molecular Biochemicals, Mannheim, Germany),
according to the manufacturers’ protocol (version 16.0).
DNA extraction of swabs and chlamydia cell culture har-
vest was performed as described by Wilson et al. [19].
Chlamydia suis PCR
Pig swabs were examined by real-time PCRI, a 23S rRNA-
based real-time PCR detecting C. suis in pigs [20]. How-
ever, this PCR analysis cannot be used for examining
transfer of C. suis to humans, as it also detects C. tracho-
matis. Therefore, all pig and human samples were also
examined by real-time PCRII, a recently developed C.
suis-specific 23S rRNA-based real-time PCR [15]. This
allowed the comparison between real-time PCRI and II,
for examining C. suis. Similarly, all air and contact surface
samples were analysed with PCRI and II. Samples with a
Ct-value below 35 cycles, were retested twice. Only re-
peatedly positive samples were judged as positive. Gen-
omic DNA of the C. suis reference strain S45 was used as
positive control DNA (105 particles per reaction), and
DNAse –RNAse free water as negative control.
Chlamydia trachomatis PCR
All ocular and pharyngeal swabs and urine samples of
the employees were tested for presence of C. trachoma-
tis DNA using the CE-IVD certified PRESTO Kit (Goffin
Molecular Diagnostics, Houten, The Netherlands) ac-
cording to manufacturer’s instructions [21].
Culture
All samples were examined for viable chlamydial bacteria
in cycloheximide-treated Vero cells using standard tech-
niques [22]. Positive cells were enumerated in five ran-
domly selected microscopic fields (600×, Nikon Eclipse
TE2000-E, Japan) and results were scored from 0 to 6.
Score 0 indicated that no Chlamydiae were present;
Score 1 was given when a mean of 1 to 5 non-replicating
elementary bodies (EB’s) plus maximum one inclusion
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plying EB’s was observed; scores 2 to 5 were given when
observing a mean of 2 to 5, 6 to 10, 11 to 15, 16 to >90%
inclusion positive cells [23].
Molecular characterization of Chlamydia isolates
Chlamydial isolates were molecularly characterized by
real-time PCRII [15] and DNA sequence analysis of the
16S (298 bp) and 23S (627 bp) signature sequences of
Chamydia [17]. Sequence analyses were performed by
the VIB Genetic Service Facility (University of Antwerp,
Antwerp, Belgium).
Tet(C) PCR
Chlamydia suis isolates of pigs and humans were exam-
ined for presence of the tetracycline resistance gene by
the tet(C) PCR, as described by Dugan et al. [24].
Results
Chlamydia suis in pigs
Rectal swabs of 100 pigs were examined by real-time
PCRI and II. Real-time PCRI revealed 45 (45%) positives.
The Ct-values varied between 26.6 and 32. PCRII discov-
ered 7 additional positives, resulting in a final number of
52 positives on 100 (52%) pigs (with the 95 percentage
confidence interval ranging from 24 to 66%). This find-
ing is consistent with the reported higher sensitivity of
PCRII [15] compared to PCRI [20]. The Ct-value of real-
time PCRII varied between 16.8 and 30.1. PCRII positive
pigs were found on all farms. The percentage of PCRII
positive pigs per farm ranged from 10 to 100%. Fifteen
of 52 (28.8%) PCR positive pigs excreted C. suis, as dem-
onstrated by PCRII and DNA sequencing of 16S and
23S signature sequences of obtained Chlamydia isolates.
Those 15 culture positives originated from 8 of 10 exam-
ined farms. Three of 15 (20%) C. suis isolates contained
the tet(C) gene (Figure 1). Chlamydia suis tet(C) posi-
tives were found on 3 of 10 farms.
Chlamydia suis and Chlamydia trachomatis in humans
Only 12 of 84 (14.3%) employees participated. The age
of the participants varied between 25 and 60 years with
an average of 43 years. The set of 48 human samplesFigure 1 Results of the tetracycline resistance PCR performed
on swine and human Chlamydia suis isolates. Three Chlamydia
suis strains isolated from pigs were tetC positive. The other 12
obtained swine isolates, whereof three are represented, and both
human isolates, were tetC negative.comprised: 12 conjunctival, 12 pharyngeal, 12 stool and
12 urine samples, which were all examined for C. suis
and C. trachomatis. Samples were negative for C. tracho-
matis. Pharyngeal, stool and urine samples were negative
for C. suis by both real-time PCRI and II. However, 2 of
12 (16.6%) conjunctival swabs were positive in real-time
PCRII, showing Ct-values of 26 and 28, respectively.
Those two swabs were negative by real-time PCRI. Posi-
tive real-time PCRII results were confirmed by culture
(both score 1), as we isolated C. suis from both conjunc-
tival swabs (Figure 2). None of the human C. suis iso-
lates contained the tet(C) gene (Figure 1). Both C. suis
positive employees worked daily in the abattoir. One of
them worked in the pig intestine washing room during
the last three years while the other person did the bleed-
ing of the pigs during the last eight years. They had no
clinical signs or disease complaints while being exam-
ined by the occupational physician, nor did they mention
having symptoms related to eye infections, ever since
working in the slaughterhouse.
Chlamydia suis on contact surfaces
Contact surfaces were all negative by real-time PCRI. Real-
time PCRII could discover C. suis DNA, albeit small
amounts (Ct-values ranging from 32.5 to 34.1) were de-
tected on contact surfaces of nine of the 14 sampled work
locations in the slaughterhouse. For six of these locations,
positive real-time PCRII results were confirmed by culture
(culture score 1) (Table 1).Figure 2 Micrographic image of one of the obtained human
C. suis isolates. The larger green spot, adjacent to the red stained
cell nucleus, represents a chlamydial inclusion. The small green dots
are chlamydial EBs. This image corresponds to a culture score of 1.
(Magnification 400×).
Table 1 Results of the molecular analyses on contact
surface samples at different locations in the abattoir
Location PCRII Viable
C. suis
Pig reception area - -
Slaughtering and bleeding area + +
Pre-washing bath location - -
Dehairing area + +
Cutting/deboning area - -
Carcass splitting area + -
Organ evisceration area - -
Individual weighing area + +
Chilling/hanging room - -
Pig intestine washing room + -
Employee dining room + +
Sanitary facilities at the individual wheighing area + -
Sanitary facilities at the pig intestine washing room + +
Sanitary facilities at the cloakrooms + +
Total (positives/examined) 9/14 6/14
Swabs in DNA/RNA stabilization buffer were used to detect the presence of C.
suis DNA by use of PCRI and II. The results of the PCRII analysis are mentioned
in column ‘PCRII’. Swabs in 2-SP medium were inoculated on Vero-cells for
evaluation of the presence of viable Chlamydiae. Culture positive chlamydial
isolates were analysed using PCRII for subsequent molecular detection of C.
suis. Results are shown in column ‘viable C. suis’. All culture positive samples
showed isolation score 1.
Table 2 Results of the molecular analyses on air samples
at different locations in the abattoir
Location PCRII Viable
C. suis
Isolation
score
Pig reception area + - 4
Slaughtering/bleeding area + - -
Pre-washing bath location + + 2
Dehairing area + + 2
Organ evisceration area + + 1
Individual wheighing area - - -
Chilling/hanging room + + 2
Pig intestine washing room + + 4
Dining room - - -
Administration office - - -
Total (positives/examined) 7/10 5/10
All samples were used for direct detection of C. suis DNA, by use of PCRI and II
(results in column ‘PCRII’), for inoculation on Vero cells (results in column
‘Isolation score’) and subsequent identification of C. suis (column ‘viable
C. suis’).
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Air samples were all negative by real-time PCRI. Real-
time PCRII could discover small amounts of C. suis
DNA (Ct-values ranging from 32.5–34.12) in the air of
seven of ten sampled locations. Positive real-time PCRII
results were confirmed by culture for five of these loca-
tions (Table 2).
Discussion
The present study examines the occurrence of TcR C. suis
strains in butcher hogs being slaughtered in a Belgian ab-
attoir and, at the same time, is focusing on zoonotic trans-
mission of C. suis. Chlamydia suis infections are emerging
worldwide in the pig industry [1]. Increased awareness of
veterinarians and improved diagnostics might explain, al-
beit partially, the increasing number of reports on C. suis
outbreaks in pigs [20,25]. However, we are unaware if
contact with C. suis infected pigs presents a public health
risk, in particular for pig farmers and abattoir employees.
After all, Chlamydia suis is phylogenetically highly related
to the human pathogen Chlamydia trachomatis [17].
Moreover, both pathogens cause infections of the eye and
urogenital tract in their natural hosts (reviewed by Schaut-
teet and Vanrompay [1]). Recently, Dean et al. examined
101 conjunctival samples of trachoma (preventable blind-
ness) patients who resided in a trachoma-endemic regionof Nepal [26]. They found two C. suis infections and five
mixed C. trachomatis plus C. suis infections, all leading to
trachomatous inflammation. Hence, zoonotic transmis-
sion is likely.
Besides, the number of reports on TcR C. suis infections
in pigs is augmenting [9,11,13,14,27,28]. In 2010, Schautteet
et al. demonstrated tet(C) positive C. suis strains in 10
examined Belgian farms and in 8 on 49 (16.3%) sick
pigs ending up in the autopsy room of DGZ-Animal
Health Care Flanders [12]. Hence, the previously re-
ported epidemiology of C. suis in Belgian pigs is con-
firmed by the present study since we found tet(C)
positive C. suis strains in 8 of 10 examined Belgian
farms. Therefore, a pig slaughterhouse is a confirmed
risk environment to study the zoonotic transfer of C.
suis. Employees provided urine and ocular, pharyngeal
and fresh stool swab specimens for both PCR and cul-
ture. Two of 12 examined employees tested positive for
C. suis by PCR and culture. However, only 12 of 84 em-
ployees participated, which was low compared to former
similar studies on C. psittaci zoonotic transmission in
poultry abattoirs [18]. Analysis of the answers on all ques-
tionnaires indicated that there were no clinical complaints,
and the yearly routine medical examination revealed no clin-
ical signs of infection, although viable C. suis were found in
the eyes of two employees. Both individuals worked
for several years in the abattoir, in the pig intestine
washing room and in the slaughtering and bleeding
area, respectively. Thus, exposure to blood and intes-
tinal contents seems to present a risk for transmission
to humans, but it is not strictly leading to a symptom-
atic course of infection. Employees are almost continu-
ously exposed to C. suis and therefore could have
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could have clarified this issue, however, employees did
not give their consent for blood sampling. Contact sur-
faces at both locations were equally positive by both PCR
and culture. Thus, Chlamydia suis could have ended up in
the eyes through direct contact of hands with ‘contami-
nated’ contact surfaces. Besides, bioaerosol monitoring
demonstrated high amounts (score 4) of viable C. suis in
the air of the slaughtering and bleeding area. On the other
hand, the air of the intestine washing room was C. suis
negative, which could indicate that the air is not the main
C. suis transmission route. However, further studies on
larger risk populations should be conducted to get more
insights into transmission routes and clinical conse-
quences of C. suis in humans.
Conclusion
The present study shows the presence of viable C. suis
bacteria in the eyes of two employees and in air sam-
ples and contact surfaces along the slaughter line. None
of the human C. suis isolates contained the tet(C) gene
and both humans were negative for C. trachomatis.
However, the adaptive ability of C. suis to acquire the
tet(C) gene, especially when exposed to selective pres-
sure, and the possibility of C. suis transfer to humans
could have far-reaching consequences for public health.
Preventive measures might reduce the risk of C. suis
transfer to slaughterhouse employees. Besides, further
epidemiological and clinical research towards human
ocular C. suis infections is of great importance.
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